KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia [PDF]
American Journal of Psychiatry, 2017 Robert A Hauser, Stewart A Factor
exaly +3 more sources
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference [PDF]
Movement Disorders, 2019 A minimal clinically important difference has not been established for the Abnormal Involuntary Movement Scale in patients with tardive dyskinesia.
M. Stacy +6 more
semanticscholar +2 more sources
Pathophysiology, prognosis and treatment of tardive dyskinesia. [PDF]
Ther Adv Psychopharmacol, 2022 Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most frequently affects the lower face and jaw muscles, but can also affect walking, breathing and use of the hands and limbs.
Takeuchi H, Mori Y, Tsutsumi Y.
europepmc +2 more sources
An Update on Tardive Dyskinesia: From Phenomenology to Treatment
Tremor and Other Hyperkinetic Movements, 2013 Tardive dyskinesia (TD), characterized by oro-buccal-lingual stereotypy, can manifest in the form of akathisia, dystonia, tics, tremor, chorea, or as a combination of different types of abnormal movements.
Olga Waln, J. Jankovic
semanticscholar +3 more sources
Valbenazine for tardive dyskinesia: A systematic review of the efficacy and safety profile for this newly approved novel medication—What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? [PDF]
International journal of clinical practice, 2017 The objective of this systematic review was to describe the efficacy, tolerability, and safety of valbenazine for the treatment of tardive dyskinesia (TD).
L. Citrome
semanticscholar +2 more sources
Putative role of immune reactions in the mechanism of tardive dyskinesia. [PDF]
Brain Behav Immun Health, 2023 Loonen AJM.
europepmc +2 more sources
Patient and physician perceptions of the burden of tardive dyskinesia: an international survey. [PDF]
BMJ Neurol OpenChepke C +10 more
europepmc +3 more sources
ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SYMPTOMS AND TARDIVE DYSKINESIA: ANALYSIS BASED ON A SPONTANEOUS REPORTING SYSTEM DATABASE IN JAPAN [PDF]
Int J NeuropsychopharmacolYosuke Saga +3 more
europepmc +3 more sources
Acta Psychiatrica Scandinavica, 1988 ABSTRACT— Tardive dyskinesia (TD) is a syndrome of involuntary movements that develops in predisposed individuals during neuroleptic drug treatment, with an average prevalence of 15%. Neuroleptic (antidopaminergic) drugs are the predominant etiological factor.
J, Gerlach, D E, Casey
+9 more sources